Actively Recruiting
Optimised Post-discharge Care in Older Patients After Surgery for Colon Cancer (ERAS 3.0)
Led by Copenhagen University Hospital at Herlev · Updated on 2026-03-18
60
Participants Needed
2
Research Sites
246 weeks
Total Duration
On this page
Sponsors
C
Copenhagen University Hospital at Herlev
Lead Sponsor
D
Danish Cancer Society
Collaborating Sponsor
AI-Summary
What this Trial Is About
The purpose of the study is to investigate whether an extended program (ERAS 3.0) initiated hospital discharge, can improve recovery in elderly, frail patients who have undergone surgery for colon cancer. The study is a randomised controlled trial with two groups: an intervention group receiving the ERAS 3.0 program and a control group recieving standard care. The ERAS 3.0 program includes a comprehensive geriatric health assessment, dietary counseling from a dietitian, and instructions on training and physical activity. These activities will take place in the participant's homes after hospital discharge. Data will be collected at multiple time points: at the hospital, 12 days post-discharge (at the outpatient clinic), and at 1 and 3 months post discharge in the participants' homes.
CONDITIONS
Official Title
Optimised Post-discharge Care in Older Patients After Surgery for Colon Cancer (ERAS 3.0)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 65 or older
- Preoperative Clinical Frailty Scale score between 4 and 7
- Nutritional Risk Screening tool (NRS 2002) score greater than 3
- Scheduled for elective colonic resection
- No stoma planned
- Surgery performed by minimally invasive approach (laparoscopic or robotic)
- Patients discharged to their own home
- Able to give informed consent
You will not qualify if you...
- Stoma creation during the surgery
- Conversion to open surgery (laparotomy)
- Major postoperative complications (Clavien-Dindo grade higher than 3a)
- Participation in conflicting randomized trials
- Discharged with tube feeding or parenteral nutrition
- Known food allergies to dairy or ingredients in the nutrition package
- Unable to provide informed consent
- Discharged to 24-hour municipal rehabilitation facility
- Psychological, geographical, or social conditions hindering study adherence
- Previous neoadjuvant radiotherapy or chemotherapy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
University Hospital Herlev
Herlev, Denmark, 2730
Not Yet Recruiting
2
University Hospital Herlev
Herlev, Denmark, 2730
Actively Recruiting
Research Team
E
Elna A. Dalsgaard, ph.d. student
CONTACT
J
Jacob Rosenberg, Professor, dr.med.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here